miR-219-5p plays a tumor suppressive role in colon cancer by targeting oncogene Sall4.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Oncology Report

• Publication date

  2015-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3892/or.2015.4168PMID 26238082
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• MicroRNA-182 inhibits proliferation through targeting oncogenic ANUBL1 in gastric cancer.

  2015cited by this paper
• Advances in target therapy in lung cancer

  2015cited by this paper
• miR-219-5p modulates cell growth of papillary thyroid carcinoma by targeting estrogen receptor α.

  2015cited by this paper
• SALL4 as a new biomarker for early colorectal cancers

  2015cited by this paper
• miR-182 promotes cell growth and invasion by targeting forkhead box F2 transcription factor in colorectal cancer.

  2015cited by this paper
• Wnt/β-Catenin activates MiR-183/96/182 expression in hepatocellular carcinoma that promotes cell invasion.

  2015cited by this paper
• Targeting of YAP1 by microRNA-15a and microRNA-16-1 exerts tumor suppressor function in gastric adenocarcinoma

  2015cited by this paper
• Cancer statistics, 2015

  2015cited by this paper
• A review of the evolution of systemic chemotherapy in the management of colorectal cancer.

  2015cited by this paper
• Differential expression of miRNA in rat myocardial tissues under psychological and physical stress

  2014cited by this paper
• Colorectal cancer in Chinese patients: current and emerging treatment options

  2014cited by this paper
• Imatinib: A Breakthrough of Targeted Therapy in Cancer

  2014cited by this paper
• miR-326 is downstream of Sonic hedgehog signaling and regulates the expression of Gli2 and smoothened.

  2014cited by this paper
• Trastuzumab-containing regimens for metastatic breast cancer.

  2014cited by this paper
• Targeting transcription factor SALL4 in acute myeloid leukemia by interrupting its interaction with an epigenetic complex.

  2013cited by this paper
• Role of targeted agents in metastatic colorectal cancer

  2013cited by this paper
• miR-219-5p Inhibits Receptor Tyrosine Kinase Pathway by Targeting EGFR in Glioblastoma

  2013cited by this paper
• Oncofetal gene SALL4 in aggressive hepatocellular carcinoma.

  2013cited by this paper
• Miravirsen (SPC3649) can inhibit the biogenesis of miR-122

  2013cited by this paper
• Role of SALL4 in the progression and metastasis of colorectal cancer

  2013cited by this paper
• MicroRNA-200a Promotes Anoikis Resistance and Metastasis by Targeting YAP1 in Human Breast Cancer

  2013cited by this paper
• miR-375 Inhibits Proliferation of Mouse Pancreatic Progenitor Cells by Targeting YAP1

  2013cited by this paper
• Clinical Applications for microRNAs in Cancer

  2013cited by this paper
• Network signatures of cellular immortalization in human lymphoblastoid cell lines.

  2013cited by this paper
• Low-expression of microRNA-107 inhibits cell apoptosis in glioma by upregulation of SALL4.

  2013cited by this paper
• Effect of oxaliplatin, fluorouracil, and leucovorin with or without cetuximab on survival among patients with resected stage III colon cancer: a randomized trial.

  2012cited by this paper
• The role of microRNA in metastatic colorectal cancer and its significance in cancer prognosis and treatment.

  2012cited by this paper
• Adjuvant bevacizumab in colon cancer: where did we go wrong?

  2012cited by this paper
• Phase III trial of cetuximab with continuous or intermittent fluorouracil, leucovorin, and oxaliplatin (Nordic FLOX) versus FLOX alone in first-line treatment of metastatic colorectal cancer: the NORDIC-VII study.

  2012cited by this paper
• MiR‐219‐5p inhibits hepatocellular carcinoma cell proliferation by targeting glypican‐3

  2012cited by this paper
• The role of stem cell factor SALL4 in leukemogenesis.

  2011cited by this paper
• Sequencing therapies: the role of targeted agents in metastatic colorectal cancer.

  2007cited by this paper
• Bmi-1 is a target gene for SALL4 in hematopoietic and leukemic cells

  2007cited by this paper
• SALL4 is directly activated by TCF/LEF in the canonical Wnt signaling pathway.

  2006cited by this paper

• SALL4/ABCB6 Axis Suppresses Ferroptosis in Colon Cancer by Mediating Mitophagy

  2025cites this paper
• Alectinib and SALL4-Targeted Fatty Acid Oxidation: A Strategy to Combat Oxaliplatin Resistance in Gastric Cancer

  2025cites this paper
• Exploring the Mechanisms of Epithelial-Mesenchymal Transition (EMT) in Breast Cancer: The Role of MicroRNA and the Therapeutic Promise of Bioactive Compounds from Edible Plants

  2025cites this paper
• Use of SATB2 and CDX2 Immunohistochemistry to Characterize and Diagnose Colorectal Cancer

  2024cites this paper
• SALL4 in gastrointestinal tract cancers: upstream and downstream regulatory mechanisms

  2024influential citation
• The new advance of SALL4 in cancer: Function, regulation, and implication

  2023cites this paper
• SALL4 advances the proliferation and tumor cell stemness of colon cancer cells through the transcription and regulation of ROBO2

  2023cites this paper
• The Complete Loss of p53 Expression Uniquely Predicts Worse Prognosis in Colorectal Cancer

  2022cites this paper
• miR-219-5p attenuates cisplatin resistance of ovarian cancer by inactivating Wnt/β-catenin signaling and autophagy via targeting HMGA2

  2022cites this paper
• Potential application of human SALL4 on oral squamous cell carcinoma

  2022cites this paper
• Overexpressed lncRNA LINC00893 Suppresses Progression of Colon Cancer by Binding with miR-146b-3p to Upregulate PRSS8

  2022cites this paper
• SALL4 Oncogenic Function in Cancers: Mechanisms and Therapeutic Relevance

  2022cites this paper
• miR-219-5p targets TBXT and inhibits breast cancer cell EMT and cell migration and invasion

  2021cites this paper
• Expression of SALL4 stemness marker in laryngeal squamous cell carcinomas (LSCCs) and its clinical significance

  2021cites this paper
• SALL Proteins; Common and Antagonistic Roles in Cancer

  2021cites this paper
• SALL4 and microRNA: The Role of Let-7

  2021influential citation
• Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer

  2021cites this paper
• MicroRNA-219 inhibits cell viability and metastasis in papillary thyroid carcinoma by targeting EYA2.

  2020cites this paper
• Inhibition of Dimethylarginine Dimethylaminohydrolase (DDAH) Enzymes as an Emerging Therapeutic Strategy to Target Angiogenesis and Vasculogenic Mimicry in Cancer

  2020cites this paper
• MicroRNA Profile Identifies miR-6165 Could Suppress Gastric Cancer Migration and Invasion by Targeting STRN4

  2020cites this paper
• miR-503-5p inhibits colon cancer tumorigenesis, angiogenesis, and lymphangiogenesis by directly downregulating VEGF-A

  2020cites this paper
• Lnc HAGLR Promotes Colon Cancer Progression Through Sponging miR‐185‐5p and Activating CDK4 and CDK6 in vitro and in vivo

  2020cites this paper
• Regulatory noncoding RNAs and the major histocompatibility complex.

  2020cites this paper
• Molecular mechanisms and clinical implications of miRNAs in drug resistance of colorectal cancer

  2020cites this paper
• Inhibition of SALL4 suppresses epithelial-to-mesenchymal transition and tumorigenicity of breast cancer cells by targeting β-catenin and vimentin

  2020cites this paper
• MicroRNA-219-5p participates in cyanotic congenital heart disease progression by regulating cardiomyocyte apoptosis

  2020cites this paper
• OTT_A_208024 1859..1869

  2020cites this paper
• lncRNA CCAT1 contributes to the growth and invasion of gastric cancer via targeting miR‐219‐1

  2019cites this paper
• MiR-219-5p suppresses cell proliferation and cell cycle progression in esophageal squamous cell carcinoma by targeting CCNA2

  2019cites this paper
• Current Evidence on miRNAs as Potential Theranostic Markers for Detecting Chemoresistance in Colorectal Cancer: A Systematic Review and Meta-Analysis of Preclinical and Clinical Studies

  2019cites this paper
• Knockdown of Sal‐like 4 expression by siRNA induces apoptosis in colorectal cancer

  2019cites this paper
• SALL4 induces radioresistance in nasopharyngeal carcinoma via the ATM/Chk2/p53 pathway

  2019cites this paper
• Knockdown of sal‐like 4 expression by small interfering RNA induces apoptosis in breast cancer cells

  2018cites this paper
• Expression of ALCAM (CD166) and PD-L1 (CD274) independently predicts shorter survival in malignant pleural mesothelioma.

  2018cites this paper
• In vivo evidence of ascorbate involvement in the generation of epigenetic DNA modifications in leukocytes from patients with colorectal carcinoma, benign adenoma and inflammatory bowel disease

  2018cites this paper
• Characteristic profiles of DNA epigenetic modifications in colon cancer and its predisposing conditions—benign adenomas and inflammatory bowel disease

  2018cites this paper
• Significant role of microRNA‑219‑5p in diabetic retinopathy and its mechanism of action.

  2018cites this paper
• Protective role of microRNA-219-5p inhibitor against spinal cord injury via liver receptor homolog-1/Wnt/β-catenin signaling pathway regulation.

  2018cites this paper
• MiR-219-5p inhibits growth and metastasis of ovarian cancer cells by targeting HMGA2

  2018cites this paper
• miR-103/miR-195/miR-15b Regulate SALL4 and Inhibit Proliferation and Migration in Glioma

  2018cites this paper
• miR-219-5p suppresses the proliferation and invasion of colorectal cancer cells by targeting calcyphosin.

  2017cites this paper
• MicroRNA-219 is downregulated in non-small cell lung cancer and inhibits cell growth and metastasis by targeting HMGA2.

  2017cites this paper
• Upregulation of miR-598 promotes cell proliferation and cell cycle progression in human colorectal carcinoma by suppressing INPP5E expression

  2017cites this paper
• MicroRNA-98 Plays a Suppressive Role in Non-Small Cell Lung Cancer Through Inhibition of SALL4 Protein Expression

  2017cites this paper
• Clinicopathologic profile, immunophenotype, and genotype of CD274 (PD-L1)-positive colorectal carcinomas

  2017cites this paper
• Involvement of miR-106b in tumorigenic actions of both prolactin and estradiol

  2017cites this paper
• MiR-219-5p Inhibits the Growth and Metastasis of Malignant Melanoma by Targeting BCL-2

  2017cites this paper
• MicroRNA-219-5p inhibits the proliferation, migration, and invasion of epithelial ovarian cancer cells by targeting the Twist/Wnt/β-catenin signaling pathway.

  2017cites this paper
• Long non-coding RNA TUG1 promotes progression of oral squamous cell carcinoma through upregulating FMNL2 by sponging miR-219.

  2017cites this paper
• MicroRNA-219-5p Represses the Proliferation, Migration, and Invasion of Gastric Cancer Cells by Targeting the LRH-1/Wnt/β-Catenin Signaling Pathway

  2017cites this paper
• miR-219-5p targets CaMKIIγ to attenuate morphine tolerance in rats

  2017cites this paper
• Distinct pattern of epigenetic DNA modification in leukocytes from patients with colorectal carcinoma and individuals with precancerous conditions, benign adenoma and inflammatory bowel disease – a link to oxidative stress

  2017cites this paper
• Expanding the avian micro RNA repertoire of domesticated poultry and investigating the NLRP3 inflammasome messenger RNA and micro RNA transcriptomes in Anas platyrhynchos (ducks)

  2017cites this paper
• Functional and clinical significance of SALL4 in breast cancer

  2016cites this paper